カテゴリ： GlobalData, アメリカ, 企業調査

Meridian Bioscience Inc (VIVO)：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：Meridian Bioscience Inc (VIVO) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C7127
◆発行会社（調査会社）：GlobalData
◆発行日：2018年10月
◆ページ数：61
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Meridian Bioscience Inc (Meridian) is a fully integrated life science company that carries out the development, manufacturing and distribution of diagnostic test kits for viral, gastrointestinal, respiratory and parasitic infectious disease indications. It also manufactures bulk antigens, antibodies, purified reagents, nucleotides and related products for use in research and diagnostic manufacturing. The company develops proteins and other biological materials for use in biotechnology research for new drugs and vaccines. Meridian offers its products to acute care hospitals, outpatient clinics, reference laboratories and physician office laboratories in several countries worldwide. The company has presence in the US, Europe, Africa and the Middle East through direct offices and subsidiaries. Meridian is headquartered in Cincinnati, Ohio, the US.

Meridian Bioscience Inc (VIVO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Meridian Bioscience Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Meridian Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Meridian Bioscience Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Meridian Bioscience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Meridian Bioscience Inc, Medical Equipment, Deal Details 11
Private Equity 11
Telegraph Hill Partners Acquires Dynex Technologies 11
Partnerships 12
Meridian Bioscience Enters into Licensing Agreement with University of Tennessee for Electrokinetic Sensor Technology 12
Magellan Diagnostics Enters into Distribution Agreement with Biofirm Technologies 13
Microbix Biosystems Enters into Distribution Agreement with Meridian Life Science 14
Magellan Diagnostics Enters into Distribution Agreement with MedCaptain Medical Technology 15
Biohit Enters Into Distribution Agreement With Dynex Technologies 16
Equity Offering 17
Meridian Bioscience Plans to Raise USD100 Million in Public Offering of Securities 17
Acquisition 18
Meridian Bioscience Acquires Magellan Diagnostics for USD66 Million 18
Meridian Bioscience Acquires Minority Stake in Oasis Diagnostics 20
Meridian Bioscience Inc – Key Competitors 21
Meridian Bioscience Inc – Key Employees 22
Meridian Bioscience Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 25
Strategy And Business Planning 25
Jul 20, 2017: Meridian Announces Wholly Foreign Owned Enterprise Office in Beijing, China 25
Financial Announcements 26
Jul 31, 2018: Meridian Bioscience reports third quarter 2018 operating results, declares regular third quarter cash dividend, and reaffirms fiscal 2018 guidance 26
Apr 26, 2018: Meridian Bioscience Reports Second Quarter 2018 Operating Results, Declares Regular Second Quarter Cash Dividend, and Updates Fiscal 2018 Guidance 28
Jan 25, 2018: Meridian Bioscience Reports Net Revenue Of $52.3 Million In Q1 fiscal 2018 30
Nov 09, 2017: Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Fourth Quarter Cash Dividend, Sets Fiscal 2018 Cash Dividend Rate, and Reaffirms Fiscal 2018 Guidance 33
Oct 19, 2017: Meridian Bioscience Comments on Preliminary Fiscal 2017 Operating Results and Provides Fiscal 2018 Revenue and Earnings Guidance 35
Jul 27, 2017: Meridian Bioscience Reports Third Fiscal Quarter 2017 Operating Results 37
Apr 27, 2017: Meridian Bioscience Reports Second Quarter 2017 Operating Results 40
Apr 27, 2017: Meridian Bioscience Reports Second Quarter 2017 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2017 Guidance 42
Jan 25, 2017: Meridian Bioscience Reports First Quarter 2017 Operating Results, Reduces Regular Cash Dividend, and Revises Fiscal 2017 Guidance Downward 44
Corporate Communications 46
Sep 24, 2018: Meridian Bioscience announces retirement of John A. Kraeutler, executive chairman of the board; appoints David C. Phillips as chairman of the board; and elects Felicia Williams to the board of directors 46
Oct 10, 2017: Meridian Bioscience Appoints Jack Kenny as Chief Executive Officer 47
Aug 08, 2017: Meridian Bioscience Elects John Rice to the Board of Directors 48
Jul 20, 2017: Meridian Announces Wholly Foreign Owned Enterprise Office in Beijing, China 49
May 10, 2017: Meridian Bioscience Engages Korn Ferry to Conduct CEO Search as John A. Kraeutler Announces Plans to Retire 50
Legal and Regulatory 51
Oct 23, 2017: Meridian Bioscience Comments on FDA Press Statement Regarding Its Warning Letter Issued to Magellan Diagnostics 51
Jul 13, 2017: Meridian Bioscience Comments on Recent FDA Press Statement 52
Government and Public Interest 53
Jun 06, 2017: Meridian Bioscience Comments on Recent FDA Posting Related to Magellan Diagnostics 53
Product News 54
Aug 02, 2017: Bioline Launches New JetSeq Clean Kit for Next-Generation Sequencing 54
Mar 27, 2017: Bioline Launches New JetSeq DNA Quantification Kits 55
Feb 08, 2017: Bioline Launches New JetSeq DNA Library Preparation Kits 56
Feb 03, 2017: Meridian Bioscience Announces the Launch of TruQuick Rapid Tests for Asia Pacific 57
Jan 09, 2017: Bioline Launches the Full Range of EPIK miRNA Assays 58
Other Significant Developments 59
Mar 21, 2018: Meridian Bioscience Realigns Organizational Structure 59
Jun 30, 2017: Meridian Bioscience Comments on Recent FDA Matters Related to Magellan Diagnostics 60
Appendix 61
Methodology 61
About GlobalData 61
Contact Us 61
Disclaimer 61

List of Tables
Meridian Bioscience Inc, Medical Equipment, Key Facts, 2017 2
Meridian Bioscience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Meridian Bioscience Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Meridian Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Meridian Bioscience Inc, Deals By Market, 2012 to YTD 2018 9
Meridian Bioscience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Telegraph Hill Partners Acquires Dynex Technologies 11
Meridian Bioscience Enters into Licensing Agreement with University of Tennessee for Electrokinetic Sensor Technology 12
Magellan Diagnostics Enters into Distribution Agreement with Biofirm Technologies 13
Microbix Biosystems Enters into Distribution Agreement with Meridian Life Science 14
Magellan Diagnostics Enters into Distribution Agreement with MedCaptain Medical Technology 15
Biohit Enters Into Distribution Agreement With Dynex Technologies 16
Meridian Bioscience Plans to Raise USD100 Million in Public Offering of Securities 17
Meridian Bioscience Acquires Magellan Diagnostics for USD66 Million 18
Meridian Bioscience Acquires Minority Stake in Oasis Diagnostics 20
Meridian Bioscience Inc, Key Competitors 21
Meridian Bioscience Inc, Key Employees 22
Meridian Bioscience Inc, Subsidiaries 23

List of Figures
Meridian Bioscience Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Meridian Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Meridian Bioscience Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Meridian Bioscience Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Meridian Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Meridian Bioscience Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Meridian Bioscience Inc (VIVO)：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • CLP Holdings Limited：発電所・企業SWOT分析
    CLP Holdings Limited - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Civica Group Limited：企業の戦略的SWOT分析
    Civica Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • North European Oil Royalty Trust (NRT)：企業の財務・戦略的SWOT分析
    Summary North European Oil Royalty Trust (NEORT) is an oil and gas trust that holds overriding royalty rights covering gas and oil production in concessions or leases. The trust holds royalty rights under contracts with German exploration and development subsidiaries. It conducts its activities on b …
  • RRB Energy Ltd：企業の戦略的SWOT分析
    RRB Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • HTC Corporation：戦略・SWOT・企業財務分析
    HTC Corporation - Strategy, SWOT and Corporate Finance Report Summary HTC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • China Gas Holdings Ltd (384)：電力：M&Aディール及び事業提携情報
    Summary China Gas Holdings Ltd (CGHL) is a gas operator and service provider. The company offers piped natural gas, compressed natural gas, liquid petroleum gas and liquefied natural gas. Its activities include construction and operation of gas stations, gas pipeline infrastructure facilities, gas t …
  • AXA Equitable Life Insurance Company：企業の戦略・SWOT・財務情報
    AXA Equitable Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary AXA Equitable Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • China Petroleum & Chemical Corp：企業の戦略・SWOT・財務分析
    China Petroleum & Chemical Corp - Strategy, SWOT and Corporate Finance Report Summary China Petroleum & Chemical Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • F-star Biotechnology Ltd-製薬・医療分野：企業M&A・提携分析
    Summary F-star Biotechnology Ltd (F-star) is a drug development company that offers novel bispecific antibodies. The company develops immuno-oncology bispecific antibody therapeutics. Its technologies comprise modular antibody technology, a proprietary engine that generates bispecific antibodies; mA …
  • Cancer Genetics Inc (CGIX)：企業の財務・戦略的SWOT分析
    Summary Cancer Genetics Inc (CGI) is a pharmaceutical company that provides diagnostics products and services in oncology areas. The company offers products such as CGH microarrays, next-generation sequencing and DNA-FISH Probes. Its oncology tests and laboratory services offer critical genomic info …
  • Bellvitge Biomedical Research Institute：製薬・医療：M&Aディール及び事業提携情報
    Summary Bellvitge Biomedical Research Institute (IDIBELL) is a biomedical research center that offers health care development solutions. The center conducts clinical and basic research for developing treatments and techniques to improve health care. It offers its research work in the fields of neuro …
  • Maxwell Technologies Inc. (MXWL)-エネルギー分野：企業M&A・提携分析
    Summary Maxwell Technologies, Inc. (Maxwell) formerly Maxwell Laboratories, Inc., is a manufacturer of energy storage systems and power delivery solutions. The company develops, manufactures and markets energy storage and power delivery products for transportation and other applications. It also off …
  • COWI AS：企業の戦略的SWOT分析
    COWI AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Mediq NV：企業の戦略的SWOT分析
    Mediq NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Shionogi & Co Ltd (4507)：製薬・医療：M&Aディール及び事業提携情報
    Summary Shionogi & Co Ltd (Shionogi) focuses on the research, development, manufacturing and marketing of pharmaceutical products, diagnostic reagents and medical devices. The company's core pharmaceuticals product business offers drugs for the treatment of disorders in the areas of metabolism, infe …
  • US Foods, Inc.：企業の戦略・SWOT・財務分析
    US Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary US Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Dana Gas (DANA)：企業の財務・戦略的SWOT分析
    Summary Dana Gas is an oil and gas company. It produces natural gas. The company carries out the exploration and production of gas, oil, condensate, LPG and natural gas liquids. It offers processing, transportation, distribution and sales of oil, petroleum and natural gas products. Dana Gas operates …
  • aTyr Pharma Inc (LIFE)：企業の財務・戦略的SWOT分析
    Summary ATyr Pharma Inc (ATyr Pharma) is a clinical-stage biotechnology company engaged in the discovery and clinical development of medicines for the treatment of cancer and lung diseases. Its ATYR1923 is a clinical-stage product candidate, based on the resokine pathway, which binds to the neuropil …
  • Affimed GmbH (AFMD)：企業の財務・戦略的SWOT分析
    Summary Affimed GmbH (Affimed), formerly Affimed Therapeutics AG, a subsidiary of Affimed NV, discovers and develops immunotherapies to treat hematologic cancers and solid tumors. The company is investigating AFM13, an innate cell engager, for the treatment of Peripheral T cell lymphoma, transformed …
  • Booz Allen Hamilton Holding Corp (BAH)：企業の財務・戦略的SWOT分析
    Booz Allen Hamilton Holding Corp (BAH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆